Skip to content

Effects of Fospropofol Disodium on Stress Response, Immune Function, and Recovery Quality in Elderly Patients Undergoing General Anesthesia

Effects of Fospropofol Disodium on Stress Response, Immune Function, and Recovery Quality in Elderly Patients Undergoing General Anesthesia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500100320
Enrollment
Unknown
Registered
2025-04-08
Start date
2025-04-15
Completion date
Unknown
Last updated
2025-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative acute pain

Interventions

Intervention Group:The fospropofol disodium group received a continuous intravenous infusion of fospropofol disodium at an initial rate of 12.5 mg/kg/h, with a maximum infusion rate of 15 mg/kg/h.
Control Group:Anesthesia maintenance was achieved with a continuous intravenous infusion of propofol at an initial rate of 6 mg/kg/h, with a maximum infusion rate of 12 mg/kg/h.

Sponsors

Affiliated Hospital of West Anhui Health Vocational College
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to No maximum

Inclusion criteria

Inclusion criteria: (1) Patients aged >=65 years undergoing general anesthesia. (2) American Society of Anesthesiologists (ASA) physical status classification of I-II. (3) Patients scheduled for non-cardiac, non-neurosurgical, and non-hepatobiliary elective surgeries under general anesthesia, with an expected duration of =30 minutes and estimated blood loss of =500 mL.

Exclusion criteria

Exclusion criteria: (1) Patients with a known allergy to fospropofol or fospropofol disodium. (2) Patients with severe hepatic or renal insufficiency or other conditions that may affect the metabolism of anesthetic agents. (3) Patients who have recently used other anesthetic drugs or immunomodulatory agents. (4) Patients with communication barriers, no history of psychiatric or neurological disorders, and no long-term use of sedative medications. (5) Patients with suspected or confirmed history of alcohol or drug abuse. (6) Patients with allergies to any components of the study drug. (7) Patients with cardiopulmonary diseases.

Design outcomes

Primary

MeasureTime frame
Anesthesia onset time;Anesthesia recovery time;Anesthesia maintenance time;Immune Function;

Countries

China

Contacts

Public ContactJun Shen

Affiliated Hospital of West Anhui Health Vocational College

35187540@qq.com+86 182 5645 0595

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026